MeVa2.1.dOVA is a novel immune-refractory cell line to study tumor immune resistance [exome-seq]

MeVa2.1.dOVA is a novel immune-refractory cell line to study tumor immune resistance

Effect of existence or depletion of LIN28B on gene expression during tumor growth of PDAC cells

A maternal-effect Padi6 variant causes nuclear and cytoplasmic abnormalities in oocytes as well as failure of epigenetic reprogramming and zygotic genome activation in embryos [WGS]

A maternal-effect Padi6 variant causes nuclear and cytoplasmic abnormalities in oocytes as well 2 as failure of epigenetic reprogramming and zygotic genome activation in embryos

Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma.

Cancer cell genetics shaping of the tumor microenvironmentreveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma [WES 2]

RNA-Seq, WGS, WXS of mouse myeloma tumors derived from Vk*MYC transgenic mice

Conditionally Replicative Adenovirus as a Therapy for Malignant Peripheral Nerve Sheath Tumors

Brd4::Nutm1 fusion gene initiates NUT carcinoma in vivo [WGS]

Neoantigen identification for 1956 and F244 murine MCA-sarcomas

Whole genome sequencing of mouse sarcoma clones

COMPASS complex inhibition targets the metastasis initiating cell in undifferentiated pleomorphic sarcoma

Whole-exome sequencing analysis of HNM007, AKR, and NOOC1 cells.

Whole exome sequencing of NT2.5 and NT2.5-LM cell lines

Spatially exploring RNA biology in archival formalin-fixed paraffin-embedded tissues